Virulence associated with fluconazole (FL) resistance in Candida glabrata is a global problem and has not been well characterized at the proteome level. In this study, a stable FL-resistant (MIC .256 mg ml "1 ) strain of C. glabrata was generated on agar containing FL. Eight phenotypic mutants were characterized by contour-clamped homogeneous electrophoretic field analysis and two-dimensional PAGE. The secondary derivatives of C. glabrata yielded four distinct genotypes with varying chromosomal profiles. Proteomic analysis performed by tandem mass spectrometry for two of the mutants, CG L2 and CG S3 , demonstrated a total of 25 differentially regulated proteins of which 13 were upregulated and 12 were downregulated or were similar compared with the parental isolate. The mRNA transcript levels of significantly (P,0.001) upregulated genes were determined by quantitative RT-PCR analysis, and their physiological relevance in terms of phenotypic expression of virulence attributes was verified by conventional laboratory methodologies. The data showed that the FL resistance (MIC .256 mg ml "1 ) of CG S3 was associated with significantly upregulated (P,0.001) mRNA transcript levels of several genes -ERG11, CDR1, CDR2, MFS, MTI, TPR, VPS and EFT2 -in addition to a number of other potentially virulent genes expressed differentially at a lower level. The results demonstrated accentuated phenotypic expression of bud formation of yeast and metallothionein production associated with FL resistance in C. glabrata, which may help the fungus to colonize the host.
INTRODUCTION
Candida glabrata is a common fungal commensal of humans. During the past two decades, the species has evolved into a potent opportunistic pathogen that causes life-threatening infections in an ever-expanding population of immunosuppressed hosts (Li et al., 2007) . C. glabrata is also the most common non-Candida albicans species recovered from the oral cavities of human immunodeficiency virus-infected patients and is considered to be a leading cause of candidaemia in bloodstream infections (Hachem et al., 2008) . C. glabrata infections were found to occur at a relatively high level (nearly 46 % of 114 non-C. albicans Candida species) among cancer patients with organ and haematological malignancies (Safdar et al., 2001) . Furthermore, there is an increasing rate of colonization and infection by C. glabrata in leukaemic or bone-marrow transplant recipients (Raad et al., 2004) .
Of the currently available antifungal drugs, fluconazole (FL) is the most widely used agent for prophylaxis and therapy of candidiasis in patients with AIDS and organ or bone-marrow transplant recipients, as well as in patients in intensive care units (Hollenbach, 2008) . The positive effects of FL prophylaxis such as a decrease in Candida colonization and infection and a decrease in fungus-related mortality have been reported in compromised patients (Fidel et al., 1999) . However, reports of FL failure in similar groups of patients have also been documented (Marr et al., 2002; Saiman et al., 2000) . Additionally, on exposure to FL, the levels of resistance can increase dramatically, which selects for drug-resistant subpopulations, leading to clinically significant FL resistance (Pfaller et al., 2006) . C. glabrata is thought to acquire drug resistance as a result of its haploid nature and its ability to mutate rapidly following exposure to triazole-derived agents (Safdar et al., 2002) . Acquired resistance to the antifungal FL by C. glabrata has been ascribed to the upregulation of genes encoding ATPbinding cassette (ABC) transporters encoded by CDR1 and CDR2 (also known as PDH1). Proteomic studies of C. glabrata have also confirmed transcriptional regulation of the ABC-type drug efflux transporter Cdr1p (Rogers et al., 2006) .
Despite the considerable body of data showing that C. glabrata is highly resistant to FL both in vitro (Brun et al., 2003) and in vivo (Safdar et al., 2002) , its phenotype and associated virulence attributes once it has acquired FL resistance are incompletely understood. Therefore, the aims of the present study were as follows: (i) to determine chromosomal changes in two stable C. glabrata phenotypic mutants with acquired FL resistance in comparison with the parental strain, (ii) to evaluate qualitatively and quantitatively the protein expression profiles of C. glabrata after acquiring FL resistance, and (iii) to evaluate the possible role of some of the differentially expressed proteins in relation to metallothionein and blastospore formation.
METHODS
Parental C. glabrata strain and growth conditions. The reference laboratory strain C. glabrata ATCC 2001 was selected for this study. Identification of the organism was confirmed by a germ-tube test and an API 20C Aux identification kit (Analytical Profile Index; bioMérieux) . Stock cultures were maintained at -70 uC. After recovery, these were maintained on Sabouraud's dextrose agar (SDA; Oxoid) and stored at 4 uC during the experimental period. The purity of cultures was ensured by regular random identification.
FL preparation. A stock solution of 1 mg FL ml 21 (Pfizer-Roerig) was prepared as a suspension in dimethyl formamide and stored in aliquots at 220 uC.
Invoking FL resistance in C. glabrata. The parental C. glabrata ATCC 2001 strain was subjected to sequential FL exposure in our laboratories to invoke drug resistance. In brief, the parental C. glabrata strain was freshly cultured on SDA for 20 h at 37 uC and suspended in PBS (pH 7.2) to yield a cell concentration of 10 8 c.f.u. ml
21
. The yeast cells were then harvested by centrifugation at 2665 g for 5 min at 4 uC and resuspended in 60 ml RPMI broth. FL was added to a final concentration of 1.6 mg ml 21 (26 MIC) to a volume of 40 ml of this yeast suspension; 20 ml dimethyl formamide was added to the remaining 20 ml of the yeast suspension as the control. Both test and control tubes were incubated aerobically at 37 uC for 18-20 h. The yeast cells were then harvested by centrifugation at 2665 g for 5 min at 4 uC, washed in PBS and resuspended in RPMI broth/agar containing 1.6 mg FL ml 21 or in RPMI broth/agar devoid of FL. This procedure was repeated daily for a period of 46 days, and thereafter with incremental FL concentrations as follows: 106 MIC (8 mg ml
) for days 47-54 and 156 MIC (12 mg ml
) for days 55-61.
The scheme for exposure of the parental C. glabrata strain to sequentially increasing doses of FL to invoke resistance is shown in Fig. 1 . C. glabrata cultured on RPMI agar containing 12 mg FL ml 21 (156 MIC) produced drug-resistant (MIC .256 mg ml 21 ) morphologically variable (small to very small) colonies on day 61. Eight of these phenotypic mutants were randomly picked (CG L1 -CG L4 and CG S1 -CG S4 ) and tested for stability by culturing the yeast in RPMI agar without FL for 24 h. The resistance to FL, ketoconazole, itraconazole, voriconazole and amphotericin B was measured using Etest methodology as recommended by the manufacturer (AB Biodisk), and these isolates were maintained at 270 uC for further molecular studies.
Molecular typing. Molecular typing of the eight C. glabrata phenotypic mutants CG L1 -CG L4 and CG S1 -CG S4 was performed by using the contour-clamped homogeneous electrophoretic field (CHEF) method described by Espinel-Ingroff et al. (1999) with modifications. The electrophoretic conditions used were as follows: two-state mode with linear ramping factors; run time, 72 h; initial and final switching times, 3 and 17 min, respectively; constant voltage of 3 V cm
; and switching angle, 120u. Saccharomyces cerevisiae chromosomes (BioRad) were used as molecular size standards. The resulting gel was stained with ethidium bromide and destained in distilled water for 3 h. The DNA bands were visualized and photographed under a gel documentation system. Each specimen was analysed on two separate occasions.
Two of the phenotypic mutants, CG L2 and CG S3 , were randomly selected for proteomic and phenotypic analysis. As these mutants were morphologically very small, both isolates were also tested for mitochondrial deficiency by the following three methods: a 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) assay, growth in glycerol and the tetrazolium overlay technique to detect respiratory deficiency of yeast.
XTT assay. An XTT reduction assay was performed as described previously (Jin et al., 2003) . Briefly, XTT (Sigma) was dissolved in PBS to a final concentration of 1 mg ml 21 . The solution was filtersterilized using a 0.22 mm pore-size filter and stored at 270 uC until required. Menadione (Sigma) solution (0.4 mM) was also prepared and filtered immediately before each assay. Prior to each assay, XTT solution was thawed and mixed with menadione solution at a ratio of 20 : 1 (v/v).
The cell pellets were washed four times with 200 ml PBS to remove loosely adherent cells. Next, 158 ml PBS, 40 ml XTT and 2 ml menadione were added to each of the pre-washed wells. After incubation in the dark for 3 h at 37 uC, 100 ml of the solution was decanted to a new well and the colorimetric change in A 490 of the solution was determined using a microtitre plate reader (Spectra-Max 340 Tunable Microplate Reader; Molecular Devices).
Characterization of respiratory capacity. The respiratory status of the two FL-resistant mutant isolates was investigated on yeast extractpeptone-glycerol medium containing 1 % (w/v) yeast extract, 2 % (w/ v) peptone and 3 % (w/v) glycerol as the sole carbon source (Hutter & Oliver, 1998) . Thus, cells unable to respire were negatively selected on this medium.
Tetrazolium overlay technique for population studies of respiration deficiency of yeast. The test medium for this assay consisted of 1.5 % Bacto agar in 0.067 M phosphate buffer (pH 7.0) with 0.1 % 2,3,5-triphenyltetrazolium chloride (TTC). Both TTC and Bacto agar were prepared as stock solutions and autoclaved separately. The test was performed by pouring 20 ml TTC agar over 3-4-day-old SDA plates bearing 50-100 yeast colonies per plate. After 1 h of overlay, the colonies were scored for colour development: white colonies indicated respiratory-deficient colonies, whereas red colonies indicated respiratory-sufficient colonies (Ogur et al., 1957) .
Protein extraction. Soluble proteins were extracted as described previously by Casanova & Chaffin (1991) with slight modifications. C. glabrata cells grown in RPMI agar with or without FL were collected by scraping the agar plates with a sterile wire loop. The cells were washed twice with PBS, harvested by centrifugation at 4500 g for 10 min at 4 uC and resuspended in 700 ml extraction buffer containing ammonium carbonate (1.89 g l 21 ) and 1 % (v/v) b-mercaptoethanol (Casanova & Chaffin, 1991) . After adding 1 g glass beads (0.5 mm diameter; Roth), the cells were vortexed for 1 min on ice for seven cycles using a Ribolyser (Hybaid-AGS). Cell debris and the glass beads were removed by centrifugation at 16 100 g for 15 min at 4 uC. The resulting supernatant contained the soluble protein fraction. The protein fraction was stored at 270 uC and the protein content was measured using a Pierce-modified Bradford assay (Bradford, 1976) .
Image analysis. Two-dimensional (2D) gels were prepared from four independent replicate cultures for each of the test yeast isolates.
For 2D-PAGE, gel images were analysed and spots were detected with PDQuest (Advanced) 2D gel analysis software (Bio-Rad Laboratories) as described previously (Rogers et al., 2006) . To refine automatic spot matching, mismatched spots were corrected manually and protein spots that were reproducible in at least three of four replicate gels (run from four independent experiments) were selected for subsequent analysis. Protein spots that showed statistically significant differences at least twofold in their mean spot volume on at least three of four gels (t-test, P,0.5) were excised from the gels.
Isolation of total fungal RNA. A loopful of the stock culture of yeast was streaked onto RPMI agar (with/without FL for control C. glabrata) and incubated at 37 uC for 18 h. The resultant cultures were harvested and washed three times in PBS. Total RNA was extracted using an SV Total RNA Isolation system (Promega) according to the manufacturer's manual. RNA was quantified using a Beckman spectrophotometer: A 260/280 readings of 1.8-2.0 confirmed the purity. Additionally, gel electrophoresis was performed to verify intact RNA.
PCR amplification of C. glabrata genes. Primers used for the amplification of the C. glabrata genes ERG11, MFS, CDR1, CDR2, MTI, MTIIa, TPR, STE20, EF2 and VPS are listed in Table 1 .
cDNA synthesis. Reverse transcription was performed on 5 mg RNA in an annealing mixture containing 1 ml oligo(dT) primer (Gibco-BRL, Life Technologies) at 70 uC for 10 min as described previously by Samaranayake et al. (2005) . The product was chilled on ice and mixed with 4 ml first-strand buffer, 2 ml 0.1 M dithiothreitol and 1 ml 10 mM dNTPs. After incubation at 43 uC for 2 min, 1 ml 200 U ml
SuperScript II reverse transcriptase was added, making a final volume of 20 ml, and the mixture was incubated at 43 uC for 90 min for cDNA synthesis (Samaranayake et al., 2005) .
Standard curve preparation. PCR was performed with the primers listed in Table 1 . Initial denaturation was carried out at 94 uC for 5 min, followed by 35 cycles at 94 uC for 30 s, 55 uC for 2 min and 72 uC for 1 min, with a final extension at 72 uC for 10 min. The PCR products were analysed by 1.5 % agarose gel electrophoresis and purified using a QIAquick Gel Extraction kit (Qiagen). The purified PCR products were quantified by the measurement of A 260 and A 280 and used for the standard curve for real-time PCR (Trama et al., 2005) . The gene copy number of PCR products was calculated as described by Luo et al. (2004) .
Quantitative real-time PCR analysis. The primers for real-time PCR were designed using Primer Express Software (Applied Biosystems) ( Table 1 ). The reaction has been described previously (Samaranayake et al., 2006) . The reaction was carried out on ABI Step One Real-time PCR System using 26 SYBR Green Master Mix (Applied Biosystems). The conditions for real-time PCR were optimized as 40 cycles of denaturation at 95 uC for 15 s and annealing and extension at 60 uC for 1 min. Quantification standards, composed of tenfold serial dilutions of PCR products, were run in conjunction with each set of samples, and a negative master-mix control (water) was included. Each experimental condition was performed in duplicate (Pabinger et al., 2009 ) and repeated at least once on different days for reproducibility. A meltingcurve assay was carried out for each experiment to confirm the specificity of the primers (Lachke et al., 2000) . 
Y. H. Samaranayake and others 2D gel electrophoresis (2DE). For protein separation in the first dimension by isoelectric focusing (IEF), 120 mg protein extract was loaded onto an immobilized pH gradient (IPG) strip, with a nonlinear pH gradient range of 3-10, 3-6 or 4-7 (Bio-Rad Laboratories). The proteins were then lysed overnight in lysis buffer containing 7 M urea, 2 M thiourea, 2 % CHAPS, 10 mM dithiothreitol and 0.5 % IPG buffer (Bio-Rad Laboratories). IEF was performed in a Protean IEF Cell (Bio-Rad Laboratories) using the following conditions: step 1, 250 V for 15 min; step 2, 4000 V for 120 min; step 3, ramp from 4000 to 70 000 V; hold at 400 V until the second separation (Kusch et al., 2008) .
Proteins were separated in the second dimension by PAGE (12.5 % acrylamide) (Kusch et al., 2008) at 200 V in a Protean II Xi cell (BioRad Laboratories). To visualize the larger-molecular-mass proteins, an 8 % acrylamide gel and IPG strip of pH 3-10 with active hydration were also used. The protein spots were stained with silver nitrate (Yan et al., 2000) or SYBRO Ruby (Molecular Probe) (Gygi et al., 2000) . Gel images were captured using a Chemi-doc system (Bio-Rad Laboratories) or a Typhoon 9410 scanner (GE Healthcare) and quantified and analysed with PDQuest (Advanced) 2-D gel analysis software (Bio-Rad Laboratories), as described previously (Rogers et al., 2006) . Experiments were conducted on three separate occasions.
Protein identification by matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry (MALDI-TOF MS).
For peptide mass fingerprinting using MALDI-TOF MS, freshly prepared reagents and a modification of previously published methods (Law et al., 2009; Wang et al., 2007) were used.
The differentially expressed proteins in SDS-PAGE gels, selected for identification (after DeCyder software analysis of the differential gel electrophoresis images), were subsequently excised from the gels and in-gel trypsin digestion was performed using an experimental protocol described by Wang et al. (2007) . The gel plugs were first washed with 50 mM ammonium bicarbonate and then 50 % (v/v) acetonitrile (ACN) in water, followed by 100 % (v/v) ACN for dehydration. After overnight digestion with trypsin (Promega) in 50 mM ammonium bicarbonate (pH 8.0) at room temperature, the peptides were extracted using sequential steps of 0.2 % (v/v) trifluoroacetic acid (TFA) in water, followed by 50 % (v/v) ACN in 0.1 % (v/v) TFA. Some of the peptide extracts were desalted using a Zip Tips C18 kit (Millipore) according to the manufacturer's protocol. The peptides were eluted with 5 ml 50 % (v/v) ACN and 0.1 % (v/v) TFA.
For MALDI-TOF peptide mass fingerprinting protein identification, MALDI mass spectra were recorded with a Voyager DE STR MALDI-TOF mass spectrometer (Applied Biosystems) that operated in the positive ion reflectron mode at 20 kV accelerating voltage. a-Cyano-4-hydroxy cinnamic acid [10 mg ml 21 in 50 % (v/v) ACN and 0.1 % (v/v) TFA] was used as the matrix. Spectra were calibrated externally using a Calmix standard (Applied Biosystems). One missed cleavage per peptide was allowed, and an initial mass tolerance of 50 p.p.m. was used in all searches. Partial carbamidomethylation for cysteine and oxidation for methionine were assumed.
Database searching. The MASCOT program (http://www. matrixscience.com/search_form_select.html) was used to identify C. glabrata proteins and to assign their potential functions against the NCBInr fungal database (http://www.ncbi.nlm.nih.gov) and the S. cerevisiae database (http://www.yeastgenome.org). One missed cleavage per peptide was allowed, and an initial mass tolerance of 20 p.p.m. was used in all database searches. Partial carbamidomethylation for cysteine and oxidation for methionine were assumed.
Phenotypic tests.
Detection of metallothionein production. Metallothionein production by switch phenotypes of C. glabrata was detected by the method described by Lachke et al. (2002) . Cells from a primary colony (cultured on RPMI agar containing 120 mg FL ml
21
) and visually homogeneous for a single switch phenotype were inoculated into liquid yeast-peptone-glucose medium containing 1 mM CuSO 4 (YPG-CuSO 4 ) and grown at 25 uC until they reached a concentration of~5610 6 c.f.u. ml
. The cells were then diluted and distributed evenly on agar plates containing YPG-CuSO 4 medium at a density of 50-70 c.f.u. per plate. The plates were incubated at 25 uC for 5-7 days, observed for the diverse switch phenotypes with varying colours and the results were captured using an acolyte colony counter (Synbiosis).
Induction of germ-tube formation. The parental C. glabrata and mutant isolates CG L2 and CG S3 were first grown on RPMI agar containing 120 mg FL ml 21 at 37 uC for 18-20 h. A yeast inoculum at a concentration of~10 5 -10 6 c.f.u. ml 21 was prepared in glass tubes with medium containing 10 or 15 % fetal calf serum (FCS). For examination of filamentous growth, these cultures were incubated at 37 uC for 2 h. A drop of the yeast suspension was then placed on a clean microscope slide and examined under a microscope (406 magnification) (Hilmioglu et al., 2007) . Formation of hyphal elements or changes in cell morphology were observed and recorded using a confocal laserscanning microscope (Fluoview FV1000; Olympus).
Assay of adherence to silicone surfaces. The parental C. glabrata and mutant isolates CG L2 and CG S3 were first grown on RPMI agar containing 120 mg FL ml 21 (156 MIC) at 37 uC for 18-20 h. A yeast inoculum at a concentration of~10 7 cells ml 21 (MacFarland standard no. 4) was prepared in RPMI. A volume of 2 ml of this yeast suspension was added to the wells of a microtitre plate and incubated with a silicone catheter disc (0.5 cm diameter) for 90 min at 37 uC in a shaker at 75 r.p.m. After adhesion, the cell suspensions were aspirated and each well was washed twice with 150 ml PBS to remove loosely adherent cells. The adhesion of yeasts to the catheter discs was quantified by an XTT reduction assay, as described previously (Samaranayake et al., 2009) .
RESULTS

Characterization of FL-resistant colonies
CHEF analysis revealed that three of the large colonies (CG L2 , CG L3 and CG L4 ) and two each of the small colonies (CG S1 and CG S4 , and CG S2 and CG S3 ) had similar chromosomal profiles with both major and minor chromosome-size polymorphisms yielding four distinct genotypes. The chromosomal DNA of CG L2 , CG L3 and CG L4 separated into eight bands ranging in size from 610 to 2200 kb, whereas bands in the ranges of 1125-1600 and 825-1020 kb were found for CG L1 . Similarly, two groups of banding patterns were observed for the smaller-sized mutant isolates: CG S1 and CG S4 demonstrated bands of 1125-1600 kb, whereas CG S2 and CG S3 had bands of 1020-1600 kb (Fig. 2) . Two of the FL-resistant phenotypes that were stable in the absence of FL (CG L2 and CG S3 ) were selected randomly for proteomic analysis. The characterization of these two phenotypes is shown in Table 2 .
2DE analysis
To increase the sensitivity and resolution of the 2DE analysis, IEF strips of three pH ranges were used. For pH range 3-10, the parental C. glabrata, CG L2 and CG S3 strains
Fluconazole exposure upregulates C. glabrata virulence yielded a mean total of 236±34, 223±51 and 188±55 proteins, respectively (Fig. 3a) . For the pH range 4-7, the mean totals were 262±50, 183±71 and 173±76, respectively (Fig. 3b ). Separation at a pH range of 4-7 was thus advantageous for the C. glabrata parental strain, because 26 more proteins were visualized than at a pH range of 3-10. However, the pH range of 3-10 allowed better separation for both the CG L2 and CG S3 strains, demonstrating an extra 35 and 15 proteins, respectively, than at pH 4-7. Because .90 % of protein spots were located within the pH range 4-7, IEF strips with a pH range of 3-6 were used to reveal additional proteins located within this acidic region. A total of 446, 209 and 179 protein spots were observed for the parental C. glabrata, CG L2 and CG S3 , respectively, in this range (Fig. 3c) . SYBRO Ruby staining patterns were similar to those obtained after silver staining of gels. In an attempt to visualize larger-molecular-mass proteins, an 8 % polyacrylamide gel and an IPG strip with a pH range of 3-10 with active rehydration was used. The results revealed even more proteins for all three yeast isolates: totals were 570 for the parental C. glabrata, 303 for CG L2 and 254 for CG S3 .
When the 2DE images for the mutants were compared with those for the parental strain after pH 3-10 IEF and 12.5 % PAGE (Fig. 3a) , a total of 38 spots were found to be upregulated and 49 downregulated by a factor of 2 in CG L2 . In showed 62 upregulated and 66 downregulated spots. After IEF with a pH range of 4-7 and 12.5 % PAGE, a lower number of differentially expressed proteins was found for both mutants: CG L2 showed upregulation of 21 and downregulation of 15 proteins, whilst CG S3 showed upregulation of 13 and downregulation of 14 proteins. After IEF with a pH range of 3-6 and 12.5 % PAGE, 34 spots were upregulated and 69 were downregulated for CG L2 , whereas 28 were upregulated and 34 were downregulated for CG S3 . A summary of the differentially expressed proteins among the three C. glabrata phenotypes (parental C. glabrata, CG L2 and CG S3 ) is given in Table 3 .
Identification of differentially expressed proteins and mRNA
Our findings indicated that the proteome of the stable FLresistant mutants differed noticeably from that of the FLsusceptible parent. 
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Journal of Medical Microbiology 62 isolates resembled each other for a few proteins, although the magnitude of change differed (Fig. 4) . Twenty proteins were common to both CG L2 and CG S3 phenotypic mutants, six of which (spot numbers S002, 1006, 7001, 8101-3, 9602 and S003) were upregulated by .1.5-fold for both mutant isolates (Table 4 ). In addition, eight of the 20 proteins were upregulated by different degrees (three by .1-fold; two by .1.5-fold and four by .2-fold) when compared with the parental C. glabrata (Fig. 4) .
Identification of differentially expressed genes
For some of these proteins, the corresponding genes were also expressed differentially, indicating a positive correlation between expression of both genes and proteins. Thus, following MS analysis, ten proteins of the two resistant phenotypes were selected for mRNA analysis and compared with the control C. glabrata. ERG11, CDR1, CDR2, MTI, MTIIa, TPR, VPS and EFT2 gene expression was significantly increased (P,0.001) in CG L2 , whereas in CG S3 , ERG11, MFS, CDR1, CDR2, MTI, TPR, EFT2 and VPS gene expression was significantly upregulated (P,0.001), whilst MTIIa gene expression was significantly downregulated (P,0.01) (Fig. 5) . However, a protein highly similar to GTPases (STE20), important in mediating the regulation of various aspects of morphogenesis, mating and the pathogenicity in eukaryotes was moderately expressed in both mutants.
Phenotypic analyses
Metallothionein production. Phenotypic switching in the mutants CG L2 and CG S3 was observed in the presence of extracellular copper ions. FL-resistant CG L2 produced colonies with brown centres, in contrast to the control C. glabrata strain (Fig. 6 ). This phenomenon is known to be associated with the production of metallothioneins, which are encoded by two distinct gene subfamilies: MTI and MTIIa (Mehra et al., 1989) . Confirming the latter, the mRNA levels of MTI and MTIIa of the two FL-resistant mutants grown on medium containing FL were significantly altered compared with the control strain, with MTI being significantly upregulated (P,0.001) and MTIIa being significantly downregulated (P,0.01) (Fig. 5) .
Induction of germ-tube formation. Both phenotypic mutants, when subcultured in growth medium supplemented with 10 or 15 % (v/v) FCS and incubated at 37 u C, induced bud formation of yeast cells. A highly significant increase in yeast cells was seen for cells grown in both concentrations of calf serum compared with in medium devoid of calf serum (P,0.01 for CG S3 in 10% FCS, P,0.001 for other comparisons) (Fig. 7a) . These yeast cells formed a large number of blastospores that resembled bunches of grapes. The extent of cell clumping or co-aggregation was greater for CG L2 than for CG S3 compared with the parental strain (Fig. 8) . Fluconazole exposure upregulates C. glabrata virulence Assay of adherence to silicone surfaces. The results of the in vitro adherence assay indicated that the adherence of the FL-resistant isolates CG S2 and CG L2 to silicone surfaces was significantly (P,0.05) higher than that of the parental C.
glabrata strain (Fig. 7b) . There was no significant difference between adherence of the two FL-resistant isolates.
DISCUSSION FL-induced antifungal resistance
The emergence of rapid resistance to azole antifungals in C. glabrata is of great concern in patients on prolonged azole prophylaxis (Bennett et al., 2004; Hajjeh et al., 2004; Pfaller et al., 2004) . A number of studies have also documented increased FL resistance in native C. glabrata strains, as well as the acquisition of new resistant strains in cohorts of the latter (Bennett et al., 2004; Marichal et al., 1997) . In C. glabrata, multiple mechanisms of azole resistance have been reported. These include increased expression of the ABC transporter genes CDR1 and CDR2 (PDH1), which results in decreased accumulation of intracellular FL (Bennett et al., 2004; Miyazaki et al., 1998; Sanglard et al., 1999) , and the increased expression of ERG11 (also known as CYP51) encoding the FL target lanosterol 14a-demethylase (Henry et al., 2000; Marichal et al., 1997; Redding et al., 2003) . There is also evidence that the upregulation of SNQ2 transcripts is correlated with the acquisition of azole antifungals (Sanguinetti et al., 2005) .
The lack of a complete database for the C. glabrata genome sequence has hampered the comprehensive characterization of molecular mechanisms that regulate FL-induced changes in C. glabrata (Dujon et al., 2004) . Nevertheless, using available databases for C. glabrata, earlier studies have documented the overexpression of a number of genes and their gene products using 2DE and MALDI-TOF MS in azole-resistant planktonic-phase C. glabrata strains (Niimi et al., 1999; Pitarch et al., 2003) . In the present study, to ensure that the genomic and proteomic changes in the yeast strains were mainly the result of FL exposure, we selected a laboratory C. glabrata ATCC strain that had had no previous exposure to antifungal agents.
Azole resistance and morphologically variable mutants
Azole-resistant petite mutants of C. glabrata have been described previously. The resistance or decreased susceptibility to azoles in C. glabrata petite mutants is associated with increased expression of CDR1 and, to a lesser extent, of CDR2, two genes encoding ABC transporters (Brun et al., 2004) . The latter petite mutants of C. glabrata obtained by FL exposure or induced by ethidium bromide are respiratory deficient and their mitochondrial origin has been confirmed by transmission electron microscopy and restriction endonuclease analysis of the mitochondrial DNA (Brun et al., 2004) .
The two morphologically variable, FL-resistant (MIC .256 mg ml
21
) C. glabrata isolates CG L2 and CG S3 observed in the current study demonstrated increased resistance to polyenes and cross-resistance to ketoconazole, voriconazole and itraconazole. Most importantly, both isolates were not respiratory deficient or mitochondrial DNA deficient, as confirmed by XTT analysis, growth in glycerol medium and a tetrazolium overlay technique. Moreover, these petite mutants demonstrated increased expression of the gene encoding the azole target ERG11, and its corresponding protein in the mutant phenotype CG S3 .
Azole resistance in C. glabrata may arise from increased expression of the gene encoding the azole target (ERG11) due to gene duplication (Miyazaki et al., 1998; vanden Bossche et al., 1992) . ERG11 overexpression has also been reported in another laboratory-derived FL-resistant C. glabrata isolate (Marichal et al., 1997) . Upregulation of ERG11 mRNA is a widely documented mechanism that confers azole resistance in C. albicans (Lopez-Ribot et al., 1998; White, 1997) . Our observation of ERG11 mRNA and protein upregulation in the CG L2 mutant confirms previous findings that decreased susceptibility to FL in C. glabrata is associated with markedly increased mRNA expression levels of cytochrome P450 lanosterol 14a-demethylase (ERG11) (Geber et al., 1995; Henry et al., 2000; Niimi et al., 2002; Vermitsky & Edlind, 2004) .
The major drug efflux pumps belong to the major facilitator superfamily (MFS) of membrane transport proteins or to the ABC superfamily. Transcriptional upregulation of multidrug transporter genes has frequently been identified in C. glabrata (Vermitsky & Edlind, 2004) , other Candida species (Katiyar & Edlind, 2001; Perea et al., 2002) and nonCandida yeasts (Posteraro et al., 2003) . In this investigation, we isolated the total proteins, not just the drug-resistant proteins. The soluble protein fraction was separated by SDS-PAGE and identified by MALDI-TOF peptide fingerprinting. As we specifically did not study plasma-bound proteins, we may not have detected the more commonly documented drug resistance (multidrug transporter) protein profiles of Fluconazole exposure upregulates C. glabrata virulence Cdr1p and Cdr2p. Nevertheless, we were able to detect both Erg11p (cytochrome P450 lanosterol 14a-demethylase) and Mfs1p (similar to MFS), widely known to cause FL drug resistance in C. glabrata. Therefore, we also evaluated the mRNA transcript levels of CDR1 and CDR2, the two representative FL-resistant genes found in C. glabrata, and observed that CG L2 and CG S3 produced adequate amounts of CDR1 and CDR2 mRNA.
Phosphatidylethanolamine-binding protein (Pebpp) was identified in the present study. This protein is found in the outer leaflet of the Candida plasma membrane. Dogra et al. (1999) has presented evidence to show that the availability of Pebpp in the plasma membrane of C. albicans correlates with the expression of the multidrug transporter gene CDR1 of C. albicans. Interestingly, in our study, the amount of Pebpp in the two FL-resistant isolates showed upregulation (by 2.53-and 2.29-fold for CG L2 and CG S3 , respectively), whilst also depicting more pronounced mRNA levels for CDR1 and CDR2 for both CG L2 and CG S3 when compared with the parental C. glabrata strain.
Although expression of the gene SNQ2 has been shown to change in FL-resistant C. glabrata (Sanguinetti et al., 2005) , Y. H. Samaranayake and others such differences in gene upregulation or protein expression were not observed in CG L2 and CG S3 , suggesting that it is unlikely that the SNQ2 gene is closely involved in azole resistance of these two C. glabrata isolates. In addition to the proteins described above, we observed the upregulation of an abundance of proteins that have not been reported previously on 2DE maps of C. glabrata, probably because previous authors primarily aimed to identify key genes responsible for drug inhibition and drug resistance mechanisms.
More recently, the overexpression of 17 gene products and the downregulation of seven proteins in C. glabrata biofilms formed in the wells of polystyrene culture plates was shown by our group as a result of antifungal exposure of the biofilm phase of C. glabrata (Seneviratne et al., 2010) . However, in the present study, where changes in the proteome following FL exposure of the planktonic phase of C. glabrata were evaluated, not one of these (up-or downregulated) proteins was observed, which demonstrates the versatility of this fungus in adapting to different environmental conditions.
Phenotypic characterization of upregulated virulence attributes
In addition to the above-described genes that were upregulated, other significantly upregulated or downregulated proteins associated with virulence in FL-resistant C. glabrata phenotypes were detected. These were the MTI and MTIIa genes involved in metallothionein production, Tprp (similar to tetratricopeptide repeat domain), which induces germ-tube formation, and 14-3-3 proteins (at least in part via an interaction with Ste20) required for filamentation.
Metallothionein production. Phenotypic switching in the mutants CG L2 and CG S3 was observed in the presence of extracellular copper ions, indicating that exposure to FL is associated with morphological changes in C. glabrata. This phenomenon is known to be associated with the production of metallothioneins, which in C. glabrata are encoded by two distinct gene subfamilies, MTI and MTIIa (Mehra et al., 1989) . Confirming the latter, the mRNA levels of MTI and MTIIa of the two FL-resistant mutants grown on medium containing copper were far greater than that of the control parental strain (P,0.05) without copper supplements. It has also been demonstrated that genes other than those involved in copper assimilation, such as HLP1, may be induced in response to rapid environmental challenge (Lachke et al., 2000) . Indeed, in C. albicans, high-frequency phenotypic switching involves the combinatorial regulation of phase-specific genes (Soll, 1997) , several of which appear to facilitate pathogenesis, including secreted proteinases and drug resistance genes.
Induction of yeast bud formation and co-aggregation.
Adherence to tissue is a pre-requisite for colonization and infection, and C. glabrata interacts with a variety of host Changes in cell morphology and increased bud formation were viewed using a confocal laser-scanning microscope.
Fluconazole exposure upregulates C. glabrata virulence extracellular matrix molecules that promote adhesion to host surfaces (Hawser & Douglas, 1994) . In the host environment, Candida exists predominantly as biofilms rather than as planktonic cells, especially on indwelling medical devices such as catheters and prostheses (Jain et al., 2007) .
C. glabrata is known to switch to pseudohyphal growth when starved of nitrogen (Csank & Haynes, 2000) , but the fungus does not form hyphae during host invasion (Lachke et al., 2002) and only budding growth has been observed in animal tissues (Fidel et al., 1999) . In this study, highly FLresistant C. glabrata mutants formed a higher number of budding yeasts and also larger aggregates than the parental control when cultured in FCS, indicating that this attribute may be associated with high FL resistance. Concomitantly, we noted upregulation of the germ-tube-promoting gene Vps55p (vacuolar protein sorting 55) and other hyphaassociated genes, TPR (tetratriocopeptico repeat domain), two Eft2p proteins and 14-3-3p, in the FL-resistant CG L2 and CG S3 isolates.
What we observed in particular was increased co-aggregation of C. glabrata blastospores in both FL-resistant isolates.
The in vitro studies indicated that adherence of the FLresistant isolates CG S3 and CG L2 to silicone surfaces was significantly higher than that of the parental C. glabrata strain. There was no significant difference between the adherence of the two FL-resistant isolates. These results may explain to some degree the increased number of catheterassociated C. glabrata infections in bloodstream infections.
Other functions. Phenotypes associated with other differentially expressed and upregulated proteins in the two mutants deserve mention. Sod1p (very similar to CuZn superoxide dismutase), Sod2p (manganese superoxide dismutase), Pebpp and Eft2p (spot no. 9602) were commonly upregulated in both CG L2 and CG S3 . Of particular interest, two proteins, Erg11p and Eft2p (spot no. 5808), which are both involved in drug resistance and protein synthesis (Vicente et al., 2009) , were differentially regulated (more than twofold in CG S3 and more than onefold for CG L2 ). Furthermore, the 14-3-3 proteins were moderately enhanced for both mutants, consistent with their multifunctionality and the fact that they are required for filamentation via an interaction with Ste20p (Roberts et al., 1997) and have been reported to play a key role in Candida virulence (Lo et al., 1997) .
In addition to the abovementioned proteins, transcriptome analysis showed that C. glabrata exposed to FL differentially expressed a number of other proteins involved in a variety of different physiological pathways currently associated with putative virulence attributes: Lpd1p, RPS2p (associated with virulence), Tdh3p (similar to glyceraldehyde 3-phosphate dehydrogenase), Gndp (6-phosphogluconate dehydrogenase), proteins involved in physiological processes involved in carbohydrate metabolism and in reversible oxidative decarboxylation cell viability, GTPase protein (similar to Ste20) and genes involved in the stress responses such as cell-wall integrity. However, to date, the importance and impact of these proteins on the pathobiology of drug-resistant C. glabrata have not been evaluated, and further work, possibly in animal studies, is required to clarify this mechanism.
Conclusions
Our investigation has shown that FL resistance in C. glabrata, a means of combating the inhibitory effects of the antifungal, leads to significant changes in an array of virulence genes that are upregulated simultaneously to overcome the stress imposed by the azole. Although the virulence genes were upregulated in vitro as a result of FL exposure, it can be hypothesized that this transition of adaptation to environmental cues may prevail at sites of infection. Further characterization of proteomic changes should prove invaluable in aiding our understanding of the biological complexities associated with FL resistance in C. glabrata. Such data may help the development of novel strategies or antifungals to target these proteins effectively and to manage an increasingly important clinical infection.
